We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
Cap. Flow
-$952M
Cap. Flow %
-2.26%
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$156M
2
PLD icon
Prologis
PLD
+$150M
3
CVX icon
Chevron
CVX
+$109M
4
QCOM icon
Qualcomm
QCOM
+$101M
5
PAYC icon
Paycom
PAYC
+$90.8M

Sector Composition

Rank Sector Weight
1 Technology 18.81%
2 Healthcare 17.11%
3 Financials 12.73%
4 Industrials 9.87%
5 Consumer Discretionary 9.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZNTL icon
926
Zentalis Pharmaceuticals
ZNTL
$293M
$1.97M ﹤0.01%
482,481
-1,516,219
-76% -$16.9M
NTGR icon
927
NETGEAR
NTGR
$618M
$1.96M ﹤0.01%
127,892
+71,054
+125% +$994K
VGR
928
DELISTED
Vector Group Ltd.
VGR
$1.94M ﹤0.01%
183,913
+935
+0.5% +$9.9K
WEC icon
929
WEC Energy
WEC
$33.7B
$1.94M ﹤0.01%
24,734
+9,590
+63% +$779K
AVNS
930
DELISTED
Avanos Medical
AVNS
$1.93M ﹤0.01%
97,097
+3,938
+4% +$76.7K
AGEN
931
Agenus
AGEN
$326M
$1.92M ﹤0.01%
+114,677
New +$1.39M
VOYA icon
932
Voya Financial
VOYA
$9.09B
$1.91M ﹤0.01%
26,806
-510
-2% -$36.7K
MO icon
933
Altria Group
MO
$117B
$1.89M ﹤0.01%
41,555
-8,634
-17% -$383K
ROCK icon
934
Gibraltar Industries
ROCK
$1.33B
$1.89M ﹤0.01%
27,609
+26
+0.1% +$1.89K
AVIR icon
935
Atea Pharmaceuticals
AVIR
$419M
$1.89M ﹤0.01%
571,268
-91
-0% -$339
EL icon
936
Estee Lauder
EL
$34.6B
$1.89M ﹤0.01%
17,738
+16,493
+1,325% +$2.16M
BXC icon
937
BlueLinx
BXC
$593M
$1.88M ﹤0.01%
20,168
-13,970
-41% -$1.48M
KIM icon
938
Kimco Realty
KIM
$15.2B
$1.87M ﹤0.01%
96,075
+18,415
+24% +$345K
EBS icon
939
Emergent Biosolutions
EBS
$346M
$1.86M ﹤0.01%
273,287
+253,960
+1,314% +$1.09M
EGHT icon
940
8x8 Inc
EGHT
$260M
$1.86M ﹤0.01%
835,973
-1,374
-0.2% -$3.34K
BURL icon
941
Burlington
BURL
$14.5B
$1.85M ﹤0.01%
7,714
+666
+9% +$137K
TRIP icon
942
TripAdvisor
TRIP
$1.05B
$1.84M ﹤0.01%
103,282
+12,571
+14% +$273K
NBR icon
943
Nabors Industries
NBR
$1.3B
$1.83M ﹤0.01%
25,697
-4,298
-14% -$320K
HWC icon
944
Hancock Whitney
HWC
$5.98B
$1.82M ﹤0.01%
38,149
+1,784
+5% +$81.5K
VERX icon
945
Vertex
VERX
$2.04B
$1.82M ﹤0.01%
+50,605
New +$1.63M
OIS icon
946
Oil States International
OIS
$509M
$1.8M ﹤0.01%
406,199
+256,864
+172% +$1.23M
SWKS icon
947
Skyworks Solutions
SWKS
$12.9B
$1.79M ﹤0.01%
16,823
+1,264
+8% +$125K
F icon
948
Ford
F
$53.2B
$1.78M ﹤0.01%
141,653
-6,364
-4% -$78.7K
GGG icon
949
Graco
GGG
$12.4B
$1.77M ﹤0.01%
22,307
-2,489
-10% -$208K
CARS icon
950
Cars.com
CARS
$617M
$1.77M ﹤0.01%
89,706
+22
+0% +$402

Similar funds

Federated Hermes's Q2 2024 Portfolio in Review

As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
  • Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
  • Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
  • Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
  • Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
  • Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.